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Abstract
Background: Chronic stress has been found to be a major risk factor for various human pathologies. Stress activates the
hypothalamic-pituitary-adrenal (HPA) axis, which is tightly regulated via, among others, the glucocorticoid receptor (GR).
The activity of the GR is modulated by a variety of proteins, including the co-chaperone FK506 binding protein 51 (FKBP5).
Although FKBP5 has been associated with risk for affective disorders and has been implicated in GR sensitivity, previous
studies focused mainly on peripheral blood, while information about basal distribution and induction in the central nervous
system are sparse.
Methodology/Principal Findings: In the present study, we describe the basal expression pattern of Fkbp5 mRNA in the
brain of adult male mice and show the induction of Fkbp5 mRNA via dexamethasone treatment or different stress
paradigms. We could show that Fkbp5 is often, but not exclusively, expressed in regions also known for GR expression, for
example the hippocampus. Furthermore, we were able to induce Fkbp5 expression via dexamethasone in the CA1 and DG
subregions of the hippocampus, the paraventricular nucleus (PVN) and the central amygdala (CeA). Increase of Fkbp5 mRNA
was also found after restrained stress and 24 hours of food deprivation in the PVN and the CeA, while in the hippocampus
only food deprivation caused an increase in Fkbp5 mRNA.
Conclusions/Significance: Interestingly, regions with a low basal expression showed higher increase in Fkbp5 mRNA
following induction than regions with high basal expression, supporting the hypothesis that GR sensitivity is, at least partly,
mediated via Fkbp5. In addition, this also supports the use of Fkbp5 gene expression as a marker for GR sensitivity. In
summary, we were able to give an overview of the basal expression of fkbp5 mRNA as well as to extend the findings of
induction of Fkbp5 and its regulatory influence on GR sensitivity from peripheral blood to the brain.
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Introduction
Acute and chronic stress appear on the list of risk factors for a
steadily growing number of diseases. These illnesses range from
cardiovascular diseases [1] over metabolic disturbances [2] to
affective disorders [3,4,5]. However, not every individual experi-
encing a stressful episode will develop a disease, indicating that the
complex interplay of multiple factors is decisive. Genetic
predispositions, including polymorphisms in the gene encoding
the co-chaperone FK506 binding protein 51 (FKBP5), have been
implicated as one of these factors by various studies and
specifically gene x environment interactions are able to account
for increases in the risk to develop a stress-associated disorder
[6,7].
One of the main regulators of the mammalian stress response is
the hypothalamic-pituitary-adrenal (HPA) axis. The main effector
of this axis, the glucocorticoid hormone corticosterone (cortisol in
humans), binds to two different receptors: the high-affinity
mineralocorticoid receptor (MR) and the low affinity glucocorti-
coid receptor (GR). While the MR is already occupied under basal
corticosterone levels, the GR needs higher levels to be activated,
making the GR more prominent in the negative feedback loop [3].
The GR itself forms a heterocomplex with several other proteins,
including the chaperone heat-shock protein 90 (hsp90) as well as
the co-chaperone FKBP5, which regulates the folding and
trafficking of the GR [8,9]. In squirrel monkeys, FKBP5 was
found to reduce GR binding [10] and it could also be shown that
FKBP5 delays translocation of the GR to the nucleus in various
mammalian cell lines [11]. As FKBP5 expression can also be
induced via GR activation, the system forms an ultra-short
feedback loop to regulate GR sensitivity and has been described as
an important marker for GR sensitivity and bioavailability [12].
Disruptions of this feedback or HPA-axis deficiencies in general
have been associated with various affective disorders, stimulating
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related genes, including Fkbp5, on these effects [3]. In addition,
early trauma has been shown to exert long-lasting effects on HPA-
axis regulation [13,14,15]. Genes that influence the latter,
including Fkbp5, are thus in a central position to mediate long
term effects of stress. Functional polymorphisms have been
described in the Fkbp5 gene and these are associated with
differences in GR-function [16,6] as well an impaired negative
feedback of the HPA-axis [17]. Intriguingly, the alleles that are
associated with a prolonged cortisol response following a
psychological stressor are the very same that are associated with
an increased risk for psychiatric symptoms, including major
depression [18,19,20], bipolar disorder [21], suicide attempts
[22,23] and PTSD or related phenotypes [24,6,25].
Interestingly, a number of these genetic associations seem to be
mediated by gene x environment interactions. Only in the
presence of early trauma, these Fkbp5 risk alleles are associated
with mentioned psychiatric outcomes [6,25,22]. Dysregulation of
FKBP5 function and thereby GR-sensitivity in the aftermath of a
traumatic event might therefore be an important mediator of long-
term negative effects of trauma exposure.
Taken together, there is strong evidence to suggest an important
regulatory function of fkbp5 on modulating stress-related brain
functions and mechanisms underlying stress-associated psychiatric
disorders in humans. While a number of publications have
reported genotype effects of variations in the Fkbp5 gene, there is a
lack of information on the basal distribution as well as the
regulation of Fkbp5 gene expression by stress, especially in the
central nervous system. A study with post-mortem brains of HIV
victims investigated RNA as well as protein levels of Fkbp5 in the
prefrontal cortex [26] and prenatally stressed rats showed
differences in FKBP5 protein levels in the frontal cortex, but not
in the hippocampus, which could be returned to baseline via
treatment with various antidepressant drugs [27]. Nevertheless,
many aspects of fkbp5 and its regulation still remain obscure. In
the present study, we therefore investigated the detailed neuroan-
atomical expression pattern of Fkbp5 mRNA in the murine brain
and the effects of stress as well as exogenous glucocorticoid
treatment on its regulation.
Materials and Methods
Animals
For all experiments, male C57Bl/6N mice (Charles River
Laboratories, Maastricht, the Netherlands) at the age of 12 weeks
were used. The mice were held under standard conditions
(12L:12D light cycle, lights on at 0600 h, temperature 2362uC)
in Plexiglas cages (45625620 cm) and were allowed to acclimate
to the room for at least 2 weeks before the beginning of the
experiments. Food (Altromin 1324, Altromin GmbH, Germany)
and tap water were available ad libitum, unless specified otherwise.
All experiments were carried out in the animal facilities of the Max
Planck Institute of Psychiatry in Munich, Germany. The
experiments were carried out in accordance with the European
Communities’ Council Directive 86/609/EEC under the permit
ids 55.2-1-54-2531-79-05 and 55.2-1-54-2531-6-09. All efforts
were made to minimize animal suffering during the experiments.
The protocols were approved by the committee for the Care and
Use of Laboratory animals of the Government of Upper Bavaria,
Germany.
Sampling procedure
In order to obtain whole brains of the animals, mice were
sacrificed under isoflurane anaesthesia via decapitation. Directly
thereafter, the brain was carefully extracted, snap-frozen in pre-
cooled 2-methylbutane and stored at 280uC until further
processing. In addition, trunk blood was collected in microcen-
trifuge tubes, immediately put on ice and centrifuged at 4uC and
8000 rpm for 15 minutes. Plasma was then stored at 220uC until
further processing.
Radioimmunoassay
To determine the concentrations of corticosterone in the plasma
of the animals, a radioimmunoassay (RIA) was performed using a
commercially available kit (ImmunoChemTM Double Antibody
Corticosterone 125I RIA Kit, MP Biomedicals, LLC, Orange-
burg, NY) with a detection limit of 7.7 ng/ml following the
standard protocol.
Experiment 1 – Qualitative mapping of basal and stress-
induced expression of fkbp5 mRNA
A qualitative mapping of the Fkbp5 mRNA profile was
conducted. In addition, we wanted to get qualitative information
about the stress regulation of Fkbp5 mRNA for a more precise
design of the follow-up experiments. Animals were either left
undisturbed (CON, n=2) or subjected to 24 h of food deprivation
(FD, n=2) prior to sacrifice. During the stress, animals were kept
in their home cages and had free access to tap water. Two animals
per group were used, one brain being cut in the coronal plane, the
other in the sagittal plane, to obtain a qualitative overview of Fkbp5
mRNA expression. Animals were sacrificed directly following the
food deprivation period as described before (see sampling
procedure).
Experiment 2 – In-depth analysis of stress-induced
changes in fkbp5 mRNA expression
For the investigation of the influence of various stressors on
Fkbp5 gene expression, mice were subjected to different stress
paradigms. While control animals (CON, n=8) were left
undisturbed in their home cages, one group of mice was restrained
in a plastic tube for 30 minutes (RES, n=8). During that time, the
mice were unable to move or turn around in the tube. Following
stress, mice were returned to their home cages. Animals were
sacrificed under isoflurane anaesthesia 4 h after cessation of the
stressful episode (see Sampling procedure). Another group was
deprived of food for 24 h (FD, n=8). Mice were sacrificed directly
at the end of the stress period in the same way as described above
(see sampling procedure). Based on the mapping in experiment 1,
the hypothalamic paraventricular nucleus (PVN) and the central
amygdala (CeA) were selected as inducible regions with low basal
expression and the dorsal hippocampus as a region with high basal
expression of Fkbp5 mRNA.
Experiment 3 – Time course of GR-mediated changes in
fkbp5 mRNA expression
To further specify the time course of the gene activation, mice
were treated with dexamethasone, a potent, synthetic agonist of
the glucocorticoid receptor. Animals were injected sub-cutaneous-
ly (s.c.) with a single dose of dexamethasone (Dexa-ratiopharm,
100 mg injection solution, Ratiopharm, Germany) at a dosage of
10 mg/kg body weight (BW) with an injection volume of 150 ml
per animal (DEX, n=48). Vehicle-treated animals (VEH, n=45)
were injected with the same amount of saline. Animals were
sacrificed 1 h, 4 h, 8 h or 24 h post injection as described before
(see sampling procedure). As in experiment 2, the PVN, the CeA
and the hippocampus were investigated.
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To assess brain mRNA levels of Fkbp5, in-situ hybridisation
(ISH) was performed. Frozen brains were mounted in a cryostat
microtome and 18 mm sections were cut with a knife temperature
of -14uC and a sample temperature of -16uC. Sections were thaw-
mounted on superfrost slides, dried shortly and stored at -80uC.
Brains were cut in the coronal and sagittal plane, keeping every
fourth slice for experiment 1. For experiments 2 and 3, brains were
cut at the level of the PVN as well as the dorsal hippocampus. An
intron-spanning riboprobe for Fkbp5 was designed using Primer3
software, spanning from exon 5 to exon 9 of the murine Fkbp5
gene, with a total length of 491 base pairs (Forward primer 59-39:
CTTGGACCACGCTATGGTTT; Reverse primer 59-39:
GGATTGACTGCCAACACCTT). In-situ hybridisation using
35S-
UTP-labelled ribonucleotide probes was performed as described previously
[28]. Briefly, sections were fixed in 4% paraformaldehyde and acetylated in
0.25% acetic anhydride. Afterwards, slides were dehydrated in ascending
concentrations of alcohol. On the dried slides, hybridization buffer containing
between 1.5 and 2.0610
6 counts per minute of
35S-UTP -labelled riboprobe
was applied with a volume of 100 ml per slide. Brain sections were
coverslipped and incubated overnight at 55uC. The next day, sections were
rinsed and incubated with RNAse A. Finally, sections were desalted and
dehydrated.
Radioactively labelled slides were apposed to Kodak Biomax
MR films (Eastman Kodak Co., Rochester, NY) and were
developed using an automated developing machine. Films were
digitized and relative expression was measured by optical
densitometry using the ImageJ software (available at http://rsb.
info.nih.gov/ij; developed by Wayne Rasband, National Institutes
of Health, Bethesda, MD). For each animal, the mean of the
bilateral structures of two sections was calculated if applicable,
deducting the background from the value. Background signal was
measured in a structure not expressing Fkbp5 mRNA, which was
the stratum radiatum in the case of the hippocampus and the
amygdala as well as the peri-PVN region in case of the PVN. For
the qualitative mapping, signal intensities were grouped (- 0-10;
+10-20; ++20-60; +++ .60 mean grey levels). Slices were
counterstained with kresyl-violet after ISH for histological
assessment.
Data analysis
For statistical analyses, the commercially available program
SPSS 17 was used. All gene expression levels are given in arbitrary
units (a.u.). Comparisons of three conditions were assessed by
One-way ANOVA followed by Bonferroni post-hoc tests. For the
multifactorial datasets, Two-way ANOVA was performed, follow
by Bonferroni post-hoc tests in case of 3 or more groups or
independent-samples T-tests in case of 2 groups. Values outside
the 95% confidence interval were defined as outliers and excluded
from the analyses. Significance levels were set at p,0.05 and a
trend was recognized at p,0.1. Statistics for the tables with the
normalised values are the same as for the absolute values. Figures
were created using the SigmaPlot software (SigmaPlot 10.0) with
help of Adobe Photoshop CS3 and Adobe Illustrator CS3. For
representative images, contrast was modified for better display (all
analyses were done on unmodified images). Interaural and bregma
coordinates for the supplementary figures were taken from a brain
atlas [29].
Results
Experiment 1
A qualitative overview of Fkbp5 mRNA expression can be found
in Figure 1 for the sagittal plane and in Figure 2 for the coronal
Figure 1. Qualitative overview of fkbp5 mRNA expression in sagittal slices. (A)–(F) Selected slices throughout the brain. (D) Black
arrowheads point at the motor nuclei of the nervus trigeminus and nervus facialis.( E) Black arrowhead highlights the premammilary nucleus. (F) Black
arrowhead shows the hypothalamic PVN. (G) Coronal overview depicting the level of the selected slices. Autoradiographs with a white frame were
from the control condition, autoradiographs with a black frame were from the FD condition.
doi:10.1371/journal.pone.0016883.g001
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definitions of the regions and histological staining can be found in
the supplementary Figures S1, S2, S3, S4, S5, S6, S7, S8, S9 and
S10. Induction of gene expression via FD was ubiquitous over the
brain, but most prominent in regions with the low basal expression
like the hypothalamic PVN or the central amygdala.
Experiment 2
Fkbp5 gene expression was analysed in unstressed control
animals, 4 h after restrained stress and at the end of a 24 h food
deprivation period. Corticosterone levels can be found in Table 2
and showed a condition effect (One-Way ANOVA; F2,21=26.794,
p,0.01) with significantly increased levels in FD, but not in
restrained animals. Gene expression was investigated in the central
amygdala, the hypothalamic PVN and the hippocampus (see
Figures 3A, 3B and 4, respectively). In case of the central
amygdala, One-way ANOVA showed a significant effect between
the conditions (One-Way ANOVA; F2,20=23.647, p,0.01) and
post-hoc testing showed increased level of Fkbp5 gene expression in
restrained animals compared to controls as well as increased levels
for food deprived animals compared to both controls and
restrained animals. The same effect was found in the PVN
(One-Way ANOVA; F2,22=81.214, p,0.01). In addition, the
data showed different regulation of Fkbp5 mRNA after different
stressors in distinct sub-regions of the hippocampus. Fkbp5 mRNA
was up-regulated in the CA1 and the DG sub-regions following
food deprivation (One-way ANOVA; CA1: F2,22=9.498, p,0.01;
DG: F2,22=5.437, p,0.05), but not following restrained stress (see
Figure 4). Neither restraint nor food deprivation had any influence
on Fkbp5 mRNA levels in the CA2 and CA3 regions. For a better
comparison between regions with low (CeA and PVN) and high
(hippocampus) basal Fkbp5 mRNA expression, relative increases
are displayed in Table 3.
Experiment 3
The temporal regulation of Fkbp5 mRNA expression was
investigated by injection of dexamethasone. In the central
amygdala, Fkbp5 gene expression was elevated significantly after
the injection (Two-way ANOVA; treatment: F1,45=84.407,
p,0.01; timepoint: F3,45=28.673, p,0.01; treatment*timepoint
interaction: F3,45=19.361, p,0.01), with significantly increased
levels 4 h and 8 h after injection and a trend after 1 h (T-test; 1 h:
T10=1.971, p=0.077; 4 h: T9=5.812, p,0.01; 8 h: T9=7.960,
p,0.01). Gene expression returned to basal levels 24 h post
injection (see Figure 5A). A similar effect was demonstrated for the
PVN (Two-way ANOVA; treatment: F1,46=78.072, p,0.01;
timepoint: F3,46=62.030, p,0.01; treatment*timepoint interac-
tion: F3,46=25.188, p,0.01), also with significant elevations in
Fkbp5 mRNA levels 4 h and 8 h following injection (T-test; 4 h:
T10=10.597, p,0.01; 8 h: T8=4.364, p,0.01). In contrast to the
central amygdala, an effect of vehicle injection was seen 8 h after
injection in the PVN (see Figure 5B). In concordance with the
second experiment, the heterogeneous hippocampal region
showed different patterns of regulation in the distinct sub-regions
(see Figure 6). ANOVA revealed differences in gene expression in
the CA1 region (Two-way ANOVA; condition: F1,93=22.817,
p,0.01; timepoint: F3,93=3.900, p,0.05; condition*timepoint
interaction: F3,93=9.383, p,0.01) with elevated Fkbp5 mRNA
levels at the 4 h and 8 h time points (T-test; 4 h: T22=3.540,
p,0.01; 8 h: T22=5.935, p,0.01). For the CA2 and CA3
regions, a significant effect of time point was found, but no effect of
condition (Two-way ANOVA; CA2: condition: n.s.; timepoint:
F3,94=9.396, p,0.01; condition*timepoint interaction:
F3,94=2.620, p=0.056; CA3: condition: n.s.; timepoint:
F3,93=8.311, p,0.01; condition*timepoint interaction: n.s.).
Finally, investigation of the DG revealed differences over time
based upon dexamethasone treatment (Two-way ANOVA;
Figure 2. Qualitative overview of fkbp5 mRNA expression in coronal slices. (A)–(H) Selected slices throughout the brain. (C) Black
arrowhead points at the hypothalamic PVN. (D) Black arrowhead shows the central amygdala. (G) Black arrowhead highlights the locus coeruleus. (H)
Black arrowhead focuses on the motor nucleus of the nervus facialis.( I) Magnification of the hypothalamic PVN from (C). (J) Magnification of the
hippocampus from (D). (K) Sagittal overview depicting the level of the selected slices. Autoradiographs with a white frame were from the control
condition, autoradiographs with a black frame were from the FD condition.
doi:10.1371/journal.pone.0016883.g002
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mepoint interaction: F3,93=9.785, p,0.01). Post-hoc analysis
specified the temporal alterations in Fkbp5 mRNA levels with a
significant increase 4 h after injection (T-test; 4 h: T22=6.512,
p,0.01) followed by a trend for decrease at 24 h (T-test; 24 h:
T22=2.064, p=0.053). Relative increases are displayed in Table 4.
Discussion
In our experiments, we demonstrated that there is an ubiquitous
basal expression of Fkbp5 mRNA throughout the adult mouse
brain with higher expression levels in specific brain areas. In
addition, we were able to induce elevated gene expression with
various stressors as well as dexamethasone treatment. Interestingly,
temporal modulation varied between different brain regions, even
within the hippocampus.
Under basal conditions, Fkbp5 mRNA was most strongly
expressed in regions also known to express the GR [30,31], such
as the hippocampal formation [32,33], the premammillary nucleus
[34] or the motor nuclei of the nervus trigeminus and nervus facialis
[35]. Intriguingly, in the hypothalamic PVN, a central part of the
HPA axis itself and also a mediator of stress response feedback,
basal expression of Fkbp5 mRNA was very low. Given the fact that
the FKBP5 protein is an important part of the chaperone complex
regulating GR function [9], expression patterns similar to GR
expression reinforce the importance of FKBP5 in modulating GR
function.
Table 1. Systematic overview of basal Fkbp5 mRNA expression.
Region EXP Region EXP
Prosencephalon Prosencephalon (continued)
Telencephalon Diencephalon
Cerebral cortex Thalamus
Isocortex Habenular nuclei +
Layer 1 - Reticular nucleus ++
Layer 2 + Bed nuclei of the stria terminalis +
Layer 3 - Hypothalamus
Layer 4 - Paraventricular nucleus +
Layer 5 + Ventral premammilary nucleus ++
Layer 6 - Anterior hypothalamic area +
Allocortex Ventromedial hypothalamic nuclei ++
Septum ++ Mesencephalon
Indusium griseum ++ Tectum
Piriform cortex ++ Inferior colliculus -
Hippocampus Superior colliculus +
Dentate gyrus +++ Tegmentum
CA1 ++ Ventral tegmental nucleus ++
CA2 +++ Cerebral peduncle -
CA3 ++ Rhombencephalon
Subiculum ++ Metencephalon
Basal ganglia Cerebellum -
Striatum Pons
Caudate putamen + Locus coeruleus ++
Nucleus accumbens Trigeminal motor nucleus ++
Shell ++ Facial nucleus ++
Core ++ Myelencephalon
Amygdaloid complex Medulla oblongata
Basolateral nucleus + Raphe nuclei -
Central nucleus ++
Medial nucleus ++
- detection similar to background, + low expression, ++ moderate expression, +++ strong expression, Exp = expression.
doi:10.1371/journal.pone.0016883.t001
Table 2. Corticosterone levels in experiment 2.
Condition Corticosterone [ng/ml]
Control 16.662.9
Restrained 32.066.9
Food deprivation 506.5686.4*{
Data are given in mean 6 SEM.
*different to control p,0.05,
{different to restrained p,0.05.
doi:10.1371/journal.pone.0016883.t002
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inducible via treatment with dexamethasone, a synthetic glucocor-
ticoid with a high affinity for the GR,and different stress paradigms.
A number of studies have shown that Fkbp5 mRNA expression can
be induced via glucocorticoid treatment in cells ex vivo or in culture
in a concentration dependent manner [12,36,37] and a strong
positive correlation between Fkbp5 mRNA and cortisol has been
reported in whole blood [16]. A recent study has also shown that
chronic treatment with corticosterone increased Fkbp5 mRNA
expression in the hypothalamus and the hippocampus as well as in
peripheral blood [38]. Thus, we were able to replicate and extend
these findings in vivo to the central nervous system, suggesting that
the proposed intracellular ultra-short feedback loop is also relevant
for this tissue. In addition, we could show that not only direct
stimulation of the GR by dexamethasone, but also stress-induced
increases in corticosterone are able to strongly induce Fkbp5
expression in the CNS. This further supports the physiological
relevance of Fkbp5 regulation during GR activation.
In the present study, we used two different stress paradigms,
restrained stress, which is believed to be a moderate stressor, as
Figure 4. Regulation of fkbp5 mRNA in the dorsal hippocampus following restrained stress or food deprivation. Expression in the (A)
CA1, (B) CA2, (C) CA3 and (D) DG subregions of the hippocampus. Upregulation of fkbp5 mRNA can be seen in the CA1 region as well as in the DG
after 24 h of food deprivation. CON = control, RES = restrained stress, FD = food deprivation. Data are given in mean 6 SEM. * different to control
p,0.05.
doi:10.1371/journal.pone.0016883.g004
Figure 3. Regulation of fkbp5 mRNA in the central amygdala and the hypothalamic PVN following restrained stress or food
deprivation. (A) In the central amygdala, fkbp5 mRNA was upregulated 4 h after restrained stress and even more pronounced after 24 h of food
deprivation. (B) In the hypothalamic PVN, a similar regulation was found. CON = control, RES = restrained stress, FD = food deprivation, CeA =
central amygdala, PVN = paraventricular nucleus. Data are given in mean 6 SEM. * different to control p,0.05.
doi:10.1371/journal.pone.0016883.g003
Fkbp5 Expression and Induction in the Mouse Brain
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lasting stressor. This is also reflected in higher corticosterone
increases in the FD condition. It should be noted here that the
presented corticosterone levels in the restrained condition were
take 4 hours after cessation of the stressor and thereby have likely
already normalised due to negative feedback. Moreover, food
deprivation is not only quantitatively different, but also qualita-
tively. As the animals are deprived of food for 24 h, this stressor
also includes a metabolic component. In the hypothalamic PVN as
well as in the CeA, we were able to show a dose-dependent
increase in Fkbp5 mRNA, with higher levels in the FD condition
and intermediate levels following restrained stress.
Not only the severity of the stressor - and thus corticosterone
levels - influence the extent of Fkbp5 mRNA induction, but also
baseline expression of Fkbp5. Regions with low Fkbp5 mRNA
baseline expression, namely the PVN and the CeA, showed a
strong increase in Fkbp5 mRNA expression levels, which could
already be induced via the milder restraint stress. In contrast,
increase in Fkbp5 mRNA was not so prominent in the
hippocampus, a region with strong basal Fkbp5 expression. In
the latter case, higher corticosterone levels are required, as
restraint stress proved to be ineffective in inducing mRNA
expression. Although we cannot complete rule out the possibility
of a simple ceiling effect in the hippocampus, we think it is highly
unlikely. The strongest increase in mRNA in the hippocampus is
187% (see Table 3) and we do not think this is already saturation,
as in the PVN and the CeA increases up to 661% are possible and
data from cell lines (lymphoblast IM9) show increases of up to
1000% [12]. This supports the hypothesis that Fkbp5 is critically
involved in regulating GR sensitivity and higher baseline levels of
Fkbp5 mRNA result in a higher resistance of the GR to
glucocorticoid hormones, as GR mediated induction of Fkbp5
mRNA was proposed as a readout of GR sensitivity [39,40].
Therefore, local baseline Fkbp5 mRNA levels can act as a marker
of GR sensitivity in that specific brain region.
Regarding the temporal dynamics of the gene expression
changes, we found that mRNA expression was up-regulated in the
CeA, the PVN and the hippocampal CA1 region 4 hours and
8 hours following dexamethasone injection and returned to
baseline after 24 hours. As described for different stress paradigms,
also the increase of Fkbp5 mRNA following exogenous glucocor-
ticoid injection was stronger in low baseline Fkbp5 regions like the
PVN and the CeA and weaker in the hippocampus, with high
basal Fkbp5 mRNA expression. The return to baseline expression
levels after 24 hours is in contrast to the findings of Vermeer et al.
showing an increase in expression 4 hours and 8 hours after
dexamethasone treatment, but also describing elevated levels of
Fkbp5 mRNA 24 hours after treatment. This displays the
differences to cell culture experiments, most likely in kinetics and
dynamics, and highlights the importance of in vivo studies. Besides
the latter possibilitites, extracellular influence might also account
for these differences. Interestingly, we found that normalisation is
heterogeneous even within the subregions of the hippocampus, as
the temporal pattern in the DG subregion showed normalisation
after 8 hours and a substantial overshoot 24 hours after the
treatment. Moreover, vehicle-treated animals also show slight
temporal variations in Fkbp5 gene expression. This might indicate
an influence of the circadian rhythm on Fkbp5 mRNA expression,
but further studies are needed for more specific statements.
All these pieces of evidence might have important implications
on our understanding of the effects of chronic stress exposure as
well as human pathology. Chronic stress in general is accompanied
Table 3. Increase in fkbp5 mRNA following different stress
paradigms.
Region Condition
Control Restrained Food deprivation
low basal fkbp5 mRNA expression
CeA 100628 264622 524665
PVN 100622 419634 661636
high basal fkbp5 mRNA expression
Hippocampus
CA1 100616 122613 187616
CA2 100612 113671 2 0 66
CA3 100614 98669 5 67
G1 0 0 681 1 0 651 1 4 66
Data are given in percentage of the mean 6 SEM. Values are normalised to
control animals.
doi:10.1371/journal.pone.0016883.t003
Figure 5. Temporal regulation of fkbp5 mRNA in the central amygdala and the hypothalamic PVN following dexamethasone
injection. (A) Fkbp5 mRNA was significantly upregulated 4 h and 8 h after dexamethasone treatment in the central amygdala, but returned to
baseline after 24 h. Upregulation can already be detected 1 h after injection as a trend. (B) The same holds true for the hypothalamic PVN. In
addition, an effect of the vehicle injection can be seen with an increase after 8 h. VEH = injected with vehicle, DEX = injected with dexamethasone,
CeA = central amygdala, PVN = paraventricular nucleus. Data are given in mean 6 SEM. * different to vehicle p,0.05, # different to vehicle p,0.1.
doi:10.1371/journal.pone.0016883.g005
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Although some counter-regulatory mechanisms, like receptor
down-regulation, are already elucidated [28], the complex
interactions of different components of the feedback machinery
are still poorly understood. Fkbp5 could likely be an important
factor. As Fkbp5 mRNA is induced under stressful conditions in
specific brain areas and high levels of Fkbp5 mRNA lead to
decreased GR sensitivity, one could hypothesise that chronic stress
could induce chronically elevated Fkbp5 levels, which in turn
would decrease GR sensitivity in a long-lasting fashion, potentially
causing elevated corticosteroid levels. This would very likely then
be a synergistic effect together with previously reported effects.
By now, many links have been found between stress and human
diseases. Not only is chronic stress a major risk factor for a
multitude of human pathologies [41,42,43], inlcuding affective
disorders like depression, but also some aspects of illnesses show an
overlap with the effects of chronic stress exposure. In the case of
depression, about 50% of all patients suffer from elevated cortisol
levels, possibly caused by a hyperactive HPA axis [44]. In addition,
maladaptions visible in the Dex/CRH test were able to predict
relapse and response rates of patients [45,46]. Human genetic
studies have shown that single mutations in the Fkbp5 gene can
have an influence on risk for depression, number of depressive
episodes and response to antidepressant treatment (reviewed in
Binder et al., 2009), clearly stressing the importance of Fkbp5 itself
in these disorders and the need for further investigation, especially
in the form of in vivo mammalian models.
Recapitulatory, we were able to describe the basal expression
pattern of Fkbp5 mRNA expression pattern in the murine brain,
which is often, but not always, expressed in GR-rich areas. In
addition, we demonstratedthat Fkbp5 expression can be induced via
two stress paradigms as well as dexamethasone injection in limbic
brain structures like the central amygdala and the hippocampus as
well as the hypothalamic PVN. Furthermore, we have shown that
GR-mediated increases in Fkbp5 mRNA expression levels were
dependent on basal Fkbp5 gene expression, with higher levels of
basal Fkbp5 mRNA associating with an attenuated response -
pointing at a strong role of Fkbp5 in GR sensitivity.
Figure 6. Temporal regulation of fkbp5 mRNA in the hippocampus following dexamethasone injection. (A) Modulation of fkbp5 mRNA
expression in the CA1 subfield of the hippocampus. An up-regulation was found 4 and 8 h after dexamethasone treatment. (B) No significant overall
effect was found for the CA2 region. (C) In the CA3 region, dexamethasone treatment had no effect. (D) Fkbp5 shows a differential regulation in the
DG with a significant increase 4 h after injection. VEH = injected with vehicle, DEX = injected with dexamethasone. Data are given in mean 6 SEM.
* different to vehicle p,0.05, # different to vehicle p,0.1.
doi:10.1371/journal.pone.0016883.g006
Table 4. Increase in fkbp5 mRNA following dexamethasone
injection.
Region Time after DEX injection
1h 4h 8h 2 4h
low basal fkbp5 mRNA expression
CeA 260665 443645 833683 105627
PVN 125614 262611 150689 8 69
high basal fkbp5 mRNA expression
Hippocampus
CA1 109691 6 6 617 205613 8567
CA2 101641 0 0 671 0 2 667 1 67
CA3 109681 0 4 610 115610 8066
DG 93661 5 2 671 1 6 610 7369
Data are given in percentage of the mean 6 SEM. Values are normalised to the
respective vehicle-treated animals.
doi:10.1371/journal.pone.0016883.t004
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Figure S1 Measured regions for the mapping. Coordi-
nates: Interaural 4.98 mm, Bregma 1.18 mm. IG indusium
griseum, S septum, CP caudate putamen, Pir piriform cortex
(layer 2), NAcC core of the nucleus accumbens, NAcS shell of the
nucleus accumbens.
(TIF)
Figure S2 Measured regions for the mapping. Coordi-
nates: Interaural 3.58 mm, Bregma -0.22 mm. BNST bed nuclei
of the stria terminalis.
(TIF)
Figure S3 Measured regions for the mapping. Coordinates:
Interaural 2.86 mm, Bregma -0.94 mm. PVN paraventricular
nucleus of the hypothalamus, AHA anterior hypothalamic area.
(TIF)
Figure S4 Measured regions for the mapping. Coordi-
nates: Interaural 2.74 mm, Bregma -1.06 mm. Hb habenular
nucleus, Rt reticular nucleus.
(TIF)
Figure S5 Measured regions for the mapping. Coordi-
nates: Interaural 1.86 mm, Bregma -1.94 mm. DG dentate gyrus,
VmHN ventromedial hypothalamic nucleus, MA medial amyg-
dala, CeA central amygdala, BLA basolateral amygdala.
(TIF)
Figure S6 Measured regions for the mapping. Coordi-
nates: Interaural 1.34 mm, Bregma -2.46 mm. vPmN ventral
premammilary nucleus.
(TIF)
Figure S7 Measured regions for the mapping. Coordi-
nates: Interaural -0.36 mm, Bregma -4.16 mm. SC superior
colliculus, DR dorsal raphe nucleus, VTN ventral tegmental
nucleus.
(TIF)
Figure S8 Measured regions for the mapping. Coordi-
nates: Interaural -1.54 mm, Bregma -5.34 mm. LC locus
coeruleus, TMN trigeminal motor nucleus, IC inferior colliculus.
(TIF)
Figure S9 Measured regions for the mapping. Coordi-
nates: Interaural -2.44 mm, Bregma -6.24 mm. FN facial nucleus.
(TIF)
Figure S10 Identification of the cortex layers. Coordi-
nates: Interaural 0.26 mm, Bregma 4.06 mm. Only the cortex is
shown. I Layer 1, II Layer 2, III Layer 3, IV Layer 4, V Layer 5,
VI Layer 6.
(TIF)
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